ES2102837T3 - 4-amino-2-(hetero)aril-butanamidas utiles como antagonistas de los receptores de 5-ht1a. - Google Patents

4-amino-2-(hetero)aril-butanamidas utiles como antagonistas de los receptores de 5-ht1a.

Info

Publication number
ES2102837T3
ES2102837T3 ES94906976T ES94906976T ES2102837T3 ES 2102837 T3 ES2102837 T3 ES 2102837T3 ES 94906976 T ES94906976 T ES 94906976T ES 94906976 T ES94906976 T ES 94906976T ES 2102837 T3 ES2102837 T3 ES 2102837T3
Authority
ES
Spain
Prior art keywords
sup
butanamides
hetero
antagonists
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94906976T
Other languages
English (en)
Inventor
Ian Anthony Cliffe
Anderson Decourtney Ifill
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
John Wyeth and Brother Ltd
Original Assignee
John Wyeth and Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by John Wyeth and Brother Ltd filed Critical John Wyeth and Brother Ltd
Application granted granted Critical
Publication of ES2102837T3 publication Critical patent/ES2102837T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

DERIVADOS DE AMIDAS DE LA FORMULA (I):R 5 NR 4 (CR{SUB,2}){SUB,2}CHR{SUP,3}CONR{SUP,1}R{SUP,2} Y SUS SALES FARMACEUTICAMENTE ACEPTABLESS SON AGENTES AGLOMERANTES 5-HTA{SUB,1A}, Y PUEDEN SER UTILIZADOS POR EJEMPLO COMO ANSIOLITICOS. LOS RADICALES, R,R{SUP,1},R{SUP,2},R{SUP,3},R{SUP,4},R{SUP,5} TIENEN SIGNIFICADOS ESPECIFICADOS.
ES94906976T 1993-03-06 1994-02-25 4-amino-2-(hetero)aril-butanamidas utiles como antagonistas de los receptores de 5-ht1a. Expired - Lifetime ES2102837T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939304632A GB9304632D0 (en) 1993-03-06 1993-03-06 Amide derivatives

Publications (1)

Publication Number Publication Date
ES2102837T3 true ES2102837T3 (es) 1997-08-01

Family

ID=10731619

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94906976T Expired - Lifetime ES2102837T3 (es) 1993-03-06 1994-02-25 4-amino-2-(hetero)aril-butanamidas utiles como antagonistas de los receptores de 5-ht1a.

Country Status (14)

Country Link
US (1) US5610295A (es)
EP (1) EP0687257B1 (es)
JP (1) JP3316214B2 (es)
AT (1) ATE154601T1 (es)
AU (1) AU6042094A (es)
DE (1) DE69403896T2 (es)
DK (1) DK0687257T3 (es)
ES (1) ES2102837T3 (es)
GB (1) GB9304632D0 (es)
GR (1) GR3024587T3 (es)
PH (1) PH31212A (es)
TW (1) TW282458B (es)
WO (1) WO1994020481A1 (es)
ZA (1) ZA941334B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5990114A (en) * 1996-02-28 1999-11-23 Recordati, S.A., Chemical And Pharmaceutical Company Use of 5-HT1A receptor antagonists for the treatment of urinary incontinence
US20040058962A1 (en) * 2002-06-14 2004-03-25 Amedeo Leonardi Phenylalkylamines and pyridylalkylamines
ITMI20021329A1 (it) * 2002-06-14 2003-12-15 Recordati Chem Pharm Nuove ossialchilammine sostituite

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8907865D0 (en) * 1989-04-07 1989-05-24 Wyeth John & Brother Ltd Tetrahydroquinoline derivatives
FR2660657B1 (fr) * 1990-04-09 1993-05-07 Adir Nouveaux derives du 3-aminochromane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5189179A (en) * 1990-08-29 1993-02-23 Merrell Dow Pharmaceuticals Inc. Serotonin 5ht1a agonists
GB9022820D0 (en) * 1990-10-19 1990-12-05 Wyeth John & Brother Ltd Piperazine derivatives

Also Published As

Publication number Publication date
DE69403896T2 (de) 1998-01-29
DE69403896D1 (de) 1997-07-24
WO1994020481A1 (en) 1994-09-15
PH31212A (en) 1998-05-05
AU6042094A (en) 1994-09-26
ATE154601T1 (de) 1997-07-15
GB9304632D0 (en) 1993-04-21
TW282458B (es) 1996-08-01
JPH08507512A (ja) 1996-08-13
ZA941334B (en) 1995-08-25
US5610295A (en) 1997-03-11
EP0687257A1 (en) 1995-12-20
EP0687257B1 (en) 1997-06-18
DK0687257T3 (da) 1997-08-18
GR3024587T3 (en) 1997-12-31
JP3316214B2 (ja) 2002-08-19

Similar Documents

Publication Publication Date Title
BG106493A (en) Heteropolycyclic compounds and their use as metabotropic glutamate receptor
AR010062A1 (es) Nuevos benzamidaldehidos y su utilizacion
ES2058185T3 (es) Derivados de camptotecina y procedimiento para su preparacion.
NO20000572D0 (no) Indolderivater som MCP-1 reseptor antagonister
AR003955A1 (es) Derivados de n-(indol-2-carbonil)-glicinamidas, procedimiento para su obtencion y composiciones que los contienen.
NO930817D0 (no) Imidazolderivater med bifenylsulfonylurea- eller bifenylsulfonyluretan-sidekjeder, fremgangsmaate for deres fremstilling og deres anvendelse
DK1003504T3 (da) Indolderivater og deres anvendelse som PCP-1-antagonister
ES2138691T3 (es) Procedimiento para la obtencion de derivados de n-acil-5-fluorocitidina.
NO20050664L (no) 2,4 substituerte indoler og anvendelse derav som 5-HT6 modulatorer
EP0303465A3 (en) Phenethanolamine derivatives
YU30492A (sh) Derivati piperidina i postupci za njihovo dobijanje
ATE212860T1 (de) Eine neuartige medizinische verwendung eines 5ht 3-antagonisten
ES2160602T3 (es) Derivados de quinolona y acridinona para el tratamiento de la incontinencia urinaria.
IT1270612B (it) Derivati eterociclo-condensatori di morfinoidi
AR025796A1 (es) Quinazolinonas
ES2164765T3 (es) Heterociclilbenzonitrilos.
ES2102837T3 (es) 4-amino-2-(hetero)aril-butanamidas utiles como antagonistas de los receptores de 5-ht1a.
DE69112432D1 (de) Derivate von methylpiperazinoazepin, verfahren zu ihrer herstellung und verwendung.
ES2154370T3 (es) Alquenil-benzoilguanidinas.
AR025797A1 (es) Quinazolinonas
ATE218138T1 (de) N-substituierte azabicycloheptan-derivate, ihre herstellung und verwendung
ES2185716T3 (es) Derivados del benzopirano y del bezotiopirano, su preparacion y su uso como agonistas de los receptores dopaminergico.
HUP0002727A2 (hu) Eljárás fibrinogén csökkentésére benzotiofénszármazékok felhasználásával
MX9204118A (es) 2-amino-1,3,4,-tiadiazoles aminoalquilsustituidos, su preparacion y su empleo.
TR199801735A2 (xx) 2-(arilfenil)amino-imidazolin türevleri.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 687257

Country of ref document: ES